Uncategorised - European Medical Journal

Hidradenitis Suppurativa Long-Term Data Shows Lasting Relief

Long-term data reveal that bimekizumab, a dual IL-17A and IL-17F inhibitor, provides sustained symptom control for patients with hidradenitis suppurativa (HS).

Degenerative Mitral Regurgitation: 10-Year Study Confirms High Survival Rates with Surgical Repair

A decade-long study confirms excellent survival and low reoperation rates for mitral valve repair at high-volume centres.

Clinical Updates on Cerliponase Alfa ▼ in Children with CLN2 Disease

This infographic details the presentation, progression, and treatment of neuronal ceroid lipofuscinosis Type 2 (CLN2 disease), a…

New Strategy Enhances PD-1 Therapy in Treatment-Resistant Cancers

Blocking GDF-15 with visugromab enhances immune checkpoint therapy, offering new hope for resistant advanced cancers.

Robotic Bronchoscopy Safely Diagnoses Peripheral Lung Lesions

A large, multicentre study has demonstrated that robotic-assisted bronchoscopy is both safe and effective for diagnosing small and peripheral lung lesions.

Contrast-Enhanced Cone-beam Breast CT Helps Predict Lymphovascular Invasion in Breast Cancer

Contrast-enhanced conebeam breast CT imaging features can help identify lymphovascular invasion status in patients with breast cancer, according to recent research.

Higher Genetic Diabetes Risk Predicts Worse Glycaemic Outcomes in Stroke Survivors

Stroke survivors with high genetic risk for type 2 diabetes face poorer blood sugar control, new study reveals.

Study Finds Sickle Cell Trait Not Linked to Exertion-Related Death

New research finds no evidence linking sickle cell trait to acute pain crises or sudden death during exertion.

Broccoli Compound Linked to Improved Blood Sugar Levels in Prediabetes

Researchers have found that sulforaphane, a chemical compound found in broccoli sprouts, can significantly improve blood sugar levels in people with prediabetes.

Enhancing Immunotherapy by Targeting Specific Receptors in Ovarian Cancer

These findings highlight a host-intrinsic mechanism responsible for the failure of PD-L1 blockade in ovarian cancer.